Skip to main content
. 2016 Sep 1;48(3):181–189. doi: 10.3947/ic.2016.48.3.181

Table 4. Clinical impact of antibiotic-resistant bacterial infection.

Factor Non-antibiotic-resistant GPB (n = 124) Antibiotic-resistant GPB (n = 31) P-valuea Non-antibiotic-resistant GNB (n = 127) Antibiotic-resistant GNB (n = 54) P-valueb
Severe complications 27 (21.8) 12 (38.7) 0.052 30 (23.6) 25 (46.3) 0.002
 Oxygen therapy 24 (19.4) 12 (38.7) 0.022 25 (19.7) 19 (35.2) 0.026
 Shock 11 (8.9) 2 (6.5) 0.664 23 (18.1) 11 (20.4) 0.722
 ICU care 5 (4.0) 5 (16.1) 0.028 16 (12.6) 10 (18.5) 0.299
 Renal dysfunction 7 (5.6) 3 (9.7) 0.420 10 (7.9) 8 (14.8) 0.153
 Mechanical ventilator care 5 (4.0) 4 (12.9) 0.079 9 (7.1) 8 (14.8) 0.103
 Hepatic dysfunction 4 (3.2) 3 (9.7) 0.143 9 (7.1) 2 (3.7) 0.510
Mortality 14 (11.3) 11 (35.5) 0.001 18 (14.2) 20 (37.0) 0.001
Mortality due to bacteremia 7 (5.6) 3 (9.7) 0.420 7 (5.5) 14 (25.9) <0.001

aP-values were determined between antibiotic-resistant and non-antibiotic-resistant GPB groups.

bP-values were determined between antibiotic-resistant and non-antibiotic-resistant GNB groups.

GPB, gram-positive bacteria; GNB, gram-negative bacteria; ICU, intensive care unit.